LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
LENSAR, Inc.NASDAQ: LNSR
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures turns positive
Q1 FY2026 capital expenditures was $0, compared with -$6K a year earlier. Trailing-twelve-month capital expenditures was -$77K. Over 3 fiscal years it compounded at -10.3% a year.
Context
- Capital expenditures amounted to 0.1% of revenue in FY2025, down 0.1 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly capital expenditures holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$19.25K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (83K) USD
- Year-over-year change
- +46.8%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (83K) | +46.8% |
| FY2024 | 2024-12-31 | (156K) | +33.9% |
| FY2023 | 2023-12-31 | (236K) | -105.2% |
| FY2022 | 2022-12-31 | (115K) | +67.5% |
| FY2021 | 2021-12-31 | (354K) | — |
Capital Expenditures vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 capital expenditures of $77K is the 8th largest of the 10 companies compared; the peer median is $305K.
- Its year-over-year change of -45.8% is the 6th highest of 7, against a peer median of -13.3%.
- Capital expenditures amounts to 0.1% of revenue for LNSR, versus a peer median of 4.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $5.43M | -41.9% | -3.0% | 4.7% | |
| LTM Mar 2026 | $4.17M | +599.6% | -44.1% | 3.9% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $1.69M | -6.5% | +5.5% | 91.5% |
| LTM Mar 2026 | $1.34M | -10.9% | -54.3% | 4.1% | |
| LTM Mar 2026 | $925K | -15.8% | -49.9% | 2.7% | |
| LTM Mar 2026 | $305K | -70.5% | +5.3% | 0.7% | |
| LTM Mar 2026 | $179.08K | — | — | 0.9% | |
| LTM Mar 2026 | $77K | -45.8% | -10.3% | 0.1% | |
| LTM Mar 2026 | $44K | — | -63.3% | 8.4% | |
| LTM Mar 2026 | $13K | — | -19.6% | — | |
| Peer median (excluding LNSR) | $305K | -13.3% | -31.8% | 4.0% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| Deferred Income Tax | 527K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.87M | 6.61M | 5.54M | 2.67M | 3.14M |
| Change in Working Capital | (42K) | (5.58M) | (7.78M) | (3.04M) | 1.1M |
| Accounts Receivables | (2.65M) | (1.44M) | 1.08M | (2.1M) | 289K |
| Inventory | 2.33M | (6.89M) | (7.46M) | (4.9M) | (13.9M) |
| Accounts Payables | 213K | 2.73M | (1.42M) | 1.96M | 12.99M |
| Other Working Capital | 66K | 23K | 23K | 2M | 1.72M |
| Other Non-Cash Items | 517K | 618K | 3.45M | 25.58M | 10.7M |
| Operating Cash Flow | (8.97M) | (14.86M) | (9.66M) | (2.28M) | (14.83M) |
| Capital Expenditures | (354K) | (115K) | (236K) | (156K) | (83K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (3.92M) | (10.25M) | (11.88M) |
| Sales of Investments | 0 | 0 | 0 | 8.24M | 13.25M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (354K) | (115K) | (4.16M) | (2.16M) | 1.28M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 361K | 408K | 0 | 58K | 258K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (2.4M) | 5.88M | 20K | 10M |
| Financing Cash Flow | 361K | (1.99M) | 19.76M | 78K | 10.26M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (8.96M) | (16.96M) | 5.95M | (4.36M) | (3.29M) |
| Free Cash Flow | (9.32M) | (14.97M) | (9.9M) | (2.43M) | (14.91M) |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.